UnitedHealth Group Incorporated $UNH Shares Sold by Coho Partners Ltd.

Coho Partners Ltd. decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 152,962 shares of the healthcare conglomerate’s stock after selling 5,123 shares during the period. UnitedHealth Group comprises 3.6% of Coho Partners Ltd.’s investment portfolio, making the stock its 13th biggest position. Coho Partners Ltd.’s holdings in UnitedHealth Group were worth $47,720,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. SilverOak Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 6.2% in the second quarter. SilverOak Wealth Management LLC now owns 4,767 shares of the healthcare conglomerate’s stock valued at $1,487,000 after purchasing an additional 279 shares during the period. Mattson Financial Services LLC lifted its holdings in UnitedHealth Group by 14.1% during the 2nd quarter. Mattson Financial Services LLC now owns 11,870 shares of the healthcare conglomerate’s stock worth $3,703,000 after buying an additional 1,467 shares in the last quarter. Empirical Asset Management LLC raised its stake in shares of UnitedHealth Group by 93.3% in the second quarter. Empirical Asset Management LLC now owns 2,436 shares of the healthcare conglomerate’s stock valued at $760,000 after acquiring an additional 1,176 shares in the last quarter. Consilio Wealth Advisors LLC raised its position in UnitedHealth Group by 28.6% in the 2nd quarter. Consilio Wealth Advisors LLC now owns 896 shares of the healthcare conglomerate’s stock valued at $277,000 after purchasing an additional 199 shares in the last quarter. Finally, S Bank Fund Management Ltd raised its position in UnitedHealth Group by 35.3% in the 2nd quarter. S Bank Fund Management Ltd now owns 10,144 shares of the healthcare conglomerate’s stock valued at $3,165,000 after purchasing an additional 2,644 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of several analyst reports. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a report on Wednesday, October 8th. The Goldman Sachs Group began coverage on shares of UnitedHealth Group in a report on Tuesday. They issued a “buy” rating and a $406.00 price objective on the stock. KeyCorp raised their price target on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Finally, Piper Sandler cut their target price on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Seventeen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Hold” and a consensus target price of $384.09.

UnitedHealth Group Stock Down 1.5%

UNH opened at $355.73 on Friday. The stock has a market capitalization of $322.17 billion, a P/E ratio of 15.41, a price-to-earnings-growth ratio of 2.33 and a beta of 0.47. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The business’s 50-day simple moving average is $327.27 and its 200-day simple moving average is $346.01. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s quarterly revenue was up 12.9% on a year-over-year basis. During the same period last year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.